The nonprofit Federation of American Societies for Experimental Biology (FASEB) sponsors a series of Science Research Conferences (SRCs) each year. These conferences offer scientists a collegial and relaxing environment to discuss and explore new findings and approaches to specific research areas. They feature small‐group settings in which scientists, faculty, postdoctoral fellows, and graduate students discuss scientific advances and share cutting‐edge research through lectures, poster sessions, and informal discussions.

The FASEB Science Research Conference on Microbial Glycobiology was held on July 13‐14, 2020. The FASEB Conference on Microbial Glycobiology is a biennial meeting that forms part of the FASEB SRC Series. The Microbial Glycobiology Conference provides in‐depth focus on emerging glycobiological topics such as host‐pathogen interactions, the human microbiome, glycan‐based vaccines and therapeutics, and industrial applications including biofilms and enzymes. This diversity recognizes the growing importance of microbial glycobiology in health and technology.

Due to the COVID‐19 pandemics, the 2020 FASEB Conference on Microbial Glycobiology was carried out in a virtual setting featuring 120 participants from different countries worldwide. The conference showcased exciting new avenues and novel research in the broad field of microbial glycobiology, covering aspects dealing with virulence and pathogenicity of microbes, as well as the critical role of microbes in the gut for health and homeostasis. The conference was organized in four thematic scientific sessions and featured Dr. M. Stephen Trent as the Keynote Speaker. He described the intricate mechanisms of adaptation of Acinetobacter baumannii, showing how this emerging, multidrug‐resistant opportunistic bacterium can survive without lipopolysaccharide and unravelling the compensatory mechanisms associated with antimicrobial resistance. His findings expand our notions on bacterial cell envelope biogenesis, providing a framework for future studies to unravel the connections between lipid A and lipopolysaccharide synthesis in general and cell wall peptidoglycan biogenesis.

非营利性的美国实验生物学学会联合会（FASEB）每年赞助一系列科学研究会议（SRC）。这些会议为科学家提供了一个轻松的大学环境，以讨论和探索针对特定研究领域的新发现和新方法。它们具有小组设置的特点，科学家，教职员工，博士后和研究生通过讲座，海报发布会和非正式讨论来讨论科学进步并分享前沿研究。

FASEB微生物糖生物学研究会议于2020年7月13日至14日举行。FASEB微生物糖生物学会议是两年一次的会议，是FASEB SRC系列会议的一部分。微生物糖生物学会议深入探讨了新兴的糖生物学主题，例如宿主-病原体相互作用，人类微生物组，基于聚糖的疫苗和治疗剂以及包括生物膜和酶在内的工业应用。这种多样性认识到微生物糖生物学在健康和技术领域的重要性日益提高。

由于COVID-19大流行，2020年FASEB微生物糖生物学会议在虚拟环境下举行，来自全球不同国家的120名与会者参加了会议。此次会议展示了微生物糖生物学领域广泛的令人振奋的新途径和新颖的研究，涵盖了涉及微生物毒力和致病性的方面，以及微生物在肠道中对健康和体内平衡的关键作用。该会议分为四个主题科学会议，以M. Stephen Trent博士为主题演讲者。他描述了鲍曼不动杆菌适应的复杂机制，显示了这种新兴的，具有多重耐药性的机会细菌如何能够在没有脂多糖的情况下生存，并揭示了与抗菌素耐药性相关的补偿机制。他的发现扩展了我们关于细菌细胞包膜生物发生的概念，为进一步研究脂类A和脂多糖合成之间的联系以及细胞壁肽聚糖生物发生之间的联系提供了框架。